Search results for: 'Biological Data Management'

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

This study provides insights into key mega trends for the buildings sector in Asia-Pacific. Global mega trends such as urbanization and economic and technological development are changing the demographics and financial outlook in Asia-Pacific, and will shape the region’s buildings sector. The trends examined are, broadly, building construction, and...